Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy

Abnormal mitochondrial function resulting in inadequate energy supply leads to sarcopenia and IR, suggesting that maintaining mitochondrial homeostasis by regulating mitophagy may be a promising strategy for sarcopenia IR therapy. Herein, we constructed sarcopenia mice model, which was treated with...

Full description

Bibliographic Details
Main Authors: Su Xiaojuan, Yang Danqi, Hu Yu, Yuan Ying, Song Le
Format: Article
Language:English
Published: De Gruyter 2023-07-01
Series:Open Life Sciences
Subjects:
Online Access:https://doi.org/10.1515/biol-2022-0648
_version_ 1827894443354619904
author Su Xiaojuan
Yang Danqi
Hu Yu
Yuan Ying
Song Le
author_facet Su Xiaojuan
Yang Danqi
Hu Yu
Yuan Ying
Song Le
author_sort Su Xiaojuan
collection DOAJ
description Abnormal mitochondrial function resulting in inadequate energy supply leads to sarcopenia and IR, suggesting that maintaining mitochondrial homeostasis by regulating mitophagy may be a promising strategy for sarcopenia IR therapy. Herein, we constructed sarcopenia mice model, which was treated with berberine and/or SIRT1/mitophagy inhibitors, and the activity of SIRT1/mitophagy signaling pathway was identified. Then, muscle tissue, blood biochemical index, inflammatory factors, GTT, and ITT were detected. We found that berberine treatment increased the body weight and alleviated d-galactose-induced weight loss in mice. SIRT1/mitophagy inhibitors suppressed the effects of berberine in the treatment of sarcopenia. The effect of berberine on the increase of muscle tissue, improving metabolic disorders, reducing the expression of inflammatory factors, and suppressing sarcopenia insulin resistance (IR) were reversed by SIRT1/mitophagy inhibitors. Our study establishes proof-of-concept to distinct the effect of berberine in sarcopenia IR, and provides strong evidence to support the hypothesis that berberine-induced SIRT1 triggers mitochondrial autophagy pathway and suppresses IR in sarcopenia.
first_indexed 2024-03-12T22:06:41Z
format Article
id doaj.art-00a9bdee95244b689a69fa96cf59ed01
institution Directory Open Access Journal
issn 2391-5412
language English
last_indexed 2024-03-12T22:06:41Z
publishDate 2023-07-01
publisher De Gruyter
record_format Article
series Open Life Sciences
spelling doaj.art-00a9bdee95244b689a69fa96cf59ed012023-07-24T11:18:21ZengDe GruyterOpen Life Sciences2391-54122023-07-011818539210.1515/biol-2022-0648Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagySu Xiaojuan0Yang Danqi1Hu Yu2Yuan Ying3Song Le4Department of Geriatric, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, ChinaDepartment of Geriatric, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, ChinaDepartment of Geriatric, Zhongshan Hospital, Fudan University, No. 180, Fenglin Road, Xuhui District, Shanghai 200032, ChinaDepartment of Geriatric, Zhongshan Hospital, Fudan University, No. 180, Fenglin Road, Xuhui District, Shanghai 200032, ChinaDepartment of Geriatric, Zhongshan Hospital, Fudan University, No. 180, Fenglin Road, Xuhui District, Shanghai 200032, ChinaAbnormal mitochondrial function resulting in inadequate energy supply leads to sarcopenia and IR, suggesting that maintaining mitochondrial homeostasis by regulating mitophagy may be a promising strategy for sarcopenia IR therapy. Herein, we constructed sarcopenia mice model, which was treated with berberine and/or SIRT1/mitophagy inhibitors, and the activity of SIRT1/mitophagy signaling pathway was identified. Then, muscle tissue, blood biochemical index, inflammatory factors, GTT, and ITT were detected. We found that berberine treatment increased the body weight and alleviated d-galactose-induced weight loss in mice. SIRT1/mitophagy inhibitors suppressed the effects of berberine in the treatment of sarcopenia. The effect of berberine on the increase of muscle tissue, improving metabolic disorders, reducing the expression of inflammatory factors, and suppressing sarcopenia insulin resistance (IR) were reversed by SIRT1/mitophagy inhibitors. Our study establishes proof-of-concept to distinct the effect of berberine in sarcopenia IR, and provides strong evidence to support the hypothesis that berberine-induced SIRT1 triggers mitochondrial autophagy pathway and suppresses IR in sarcopenia.https://doi.org/10.1515/biol-2022-0648berberinesarcopeniainsulin resistancesirt1-mediated mitophagy
spellingShingle Su Xiaojuan
Yang Danqi
Hu Yu
Yuan Ying
Song Le
Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
Open Life Sciences
berberine
sarcopenia
insulin resistance
sirt1-mediated mitophagy
title Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
title_full Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
title_fullStr Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
title_full_unstemmed Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
title_short Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
title_sort berberine suppressed sarcopenia insulin resistance through sirt1 mediated mitophagy
topic berberine
sarcopenia
insulin resistance
sirt1-mediated mitophagy
url https://doi.org/10.1515/biol-2022-0648
work_keys_str_mv AT suxiaojuan berberinesuppressedsarcopeniainsulinresistancethroughsirt1mediatedmitophagy
AT yangdanqi berberinesuppressedsarcopeniainsulinresistancethroughsirt1mediatedmitophagy
AT huyu berberinesuppressedsarcopeniainsulinresistancethroughsirt1mediatedmitophagy
AT yuanying berberinesuppressedsarcopeniainsulinresistancethroughsirt1mediatedmitophagy
AT songle berberinesuppressedsarcopeniainsulinresistancethroughsirt1mediatedmitophagy